Saracatinib, a Src kinase inhibitor, enhances the renoprotective effect of metformin and losartan in diabetic nephropathy
Sign Up to like & getrecommendations! Published in 2025 at "Archives of Physiology and Biochemistry"
DOI: 10.1080/13813455.2024.2449404
Abstract: Abstract Objective This research assesses renoprotective effects of saracatinib (Src) in diabetic nephropathy (DN) and the potential underlying processes. Materials and Methods Rats were divided into: control, DN, DN + Met + Los, DN +… read more here.
Keywords: met los; kinase inhibitor; saracatinib src; diabetic nephropathy ... See more keywords